West Virginia Code of State Rules › Agency 11 - Medicine › Title 11 - LEGISLATIVE RULE WEST VIRGINIA BOARD OF MEDICINE › Series 11-08 - Collaborative Pharmacy Practice › Section 11-8-2 - Definitions

Current through Register Vol. XLI, No. 28, July 12, 2024
For purposes of this rule, the following definitions
				  apply:
2.1. "Boards" means the West
				Virginia Board of Pharmacy, the West Virginia Board of Medicine, and the West
				Virginia Board of Osteopathic Medicine.
2.2. "Collaborating pharmacist" means a
				pharmacist licensed in West Virginia who has been verified by the Board of
				Pharmacy to engage in collaborative pharmacy practice:
With one or more collaborating physicians:
Pursuant to a collaborative pharmacy practice agreement
				  developed in accord with this rule; and
For which a complete and valid practice notification is filed
				  with the boards.
2.3.
				"Collaborating physician" means a doctor of medicine or osteopathic medicine
				fully and actively licensed to practice clinical medicine, without restriction,
				in West Virginia by the Board of Medicine or the Board of Osteopathic Medicine
				who collaborates with pharmacists:
Pursuant to a collaborative pharmacy practice agreement
				  developed in accord with this rule; and
For which a complete and valid practice notification is filed
				  with the boards.
A physician in training may also collaborate with pharmacists
				  pursuant to an active collaborative pharmacy agreement if the trainee's
				  supervising physician or medical department chair executes the collaborative
				  pharmacy practice agreement and the physician in training collaborates under
				  the supervision of the physician who executed the agreement.
2.4. "
Collaborative pharmacy
				practice
" is that practice of pharmacist care where one or more
				pharmacists have jointly agreed, on a voluntary basis, to work in conjunction
				with one or more physicians under written protocol where the pharmacist or
				pharmacists may perform certain patient care functions authorized by the
				physician or physicians under certain specified conditions and
				limitations.
2.5. "Collaborative
				pharmacy practice agreement" is a written and signed agreement, which is a
				physician directed approach, that is entered into between an individual
				physician or physician group, or for a medical provider in training where the
				agreement is signed by the supervising physician or chairperson of the medical
				department where the medical provider in training is practicing, and an
				individual pharmacist or pharmacists that provides for collaborative pharmacy
				practice for the purpose of drug therapy management of a patient.
2.6. "
Collaborative pharmacy practice
				protocol
" is the detailed written portion of the collaborative
				pharmacy practice agreement pursuant to which the authorized pharmacist will
				base drug therapy management decisions for patients.
2.7. "Controlled substances" means drugs that
				are classified by federal or state law in Schedules I, II, III, IV or V, as
				defined in W. Va. Code Chapter 60A, Article 2.
2.8. "
Drug therapy
				management
" means the review of drug therapy regimens of patients by a
				pharmacist for the purpose of evaluating and rendering advice to a physician
				regarding adjustment of the regimen in accordance with the collaborative
				pharmacy practice agreement. Decisions involving drug therapy management shall
				be made in the best interest of the patient. Drug therapy management is limited
				to:
2.8.1. Implementing, modifying, and
				managing drug therapy according to the terms of the collaborative pharmacy
				practice agreement;
2.8.2.
				Collecting and reviewing patient histories;
2.8.3. Performing patient evaluations that
				are mutually agreed upon in the collaborative agreement; and
2.8.4. Ordering screening laboratory tests
				that are dose related and specific to the patient's medication or are protocol
				driven and are also specifically set out in the collaborative pharmacy practice
				agreement between the pharmacist and physician.